Growth Opportunities in the Oral Solid Dosage Formulation Industry

Description

Personalized Medicine and Drug Delivery Technologies Enhance Future Growth Potential

This analysis provides an overview and advancements in the oral solid dosage formulation industry, including an evaluation of the current industry scenario, competitive landscape, and regulatory landscape. The scope of the analysis is global, focusing on North America (NA), Europe, Asia-Pacific (APAC), the Middle East, and Latin America (LATAM). It identifies the most prevalent and emerging business models supporting industry stakeholders in enhancing their competitiveness and service offerings. Discussions on key industry drivers and restraints, partnerships, investment and consolidation activities, disruptive technologies, recent excipient advancements, and present and future trends shed light on the industry's growth potential. Industry use cases will provide brief insights into game-changing participants working toward developing disruptive technologies and patient-centric drugs. The analysis will also help uncover growth opportunities based on megatrends and business models, clinical needs, use cases, market access strategies, and technology trends.

Research Highlights:

Impact of strategic imperatives on the industry
Growth drivers and restraints
Oral solid dosage based on API release profile
R&D pipeline and product innovations
Small molecule oral dosage market overview
Small molecule oral solid dosage formulation by therapy area
Innovations in extended-release dosage forms
Industry trends and emerging technologies
Supply chain resilience strategies – focus areas
Investment trends – Expansion and capability-building initiatives
Consolidation trends – mergers & acquisitions
company benchmarking
oral drug delivery solutions & services
Growth opportunities

Product Code: PFI7-52

Transformation Impacting the Oral Solid Dosage Formulation Growth Environment

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Oral Solid Dosage Formulation Industry

Ecosystem

Scope of Analysis
Industry Definition and Segmentation
Definition-OSD Based on API Release Profile

Growth Generator

Growth Drivers
Growth Restraints

Growth Environment

R&D Pipeline and Product Innovations
Small Molecule Oral Dosage Formulation Industry Overview
Small Molecule OSD Formulation by Therapy Area
Small Molecule OSD Formulation Therapy Area by Dosage Form

Tablet and Capsule Industry-Innovations and Emerging Trends

Innovations in Extended Release Dosage forms
Industry Trends and Emerging Technologies

Tablet and Capsule Industry-Regional Policies and Regulatory Impact

Regional Policies and Initiatives

Tablet and Capsule Industry-Manufacturing and CDMO Industry Overview

OSD Manufacturing-Production Flow
Vendor Ecosystem
Small Molecule OSD CDMO Industry Revenue
OSD CDMO Industry Overview
Supply Chain Resilience Strategies-Focus Areas

Tablet and Capsule Industry-Investment and Consolidation Trends Impacting Growth Themes

Investment Trends-Expansion and Capability Building
Consolidation Trends-Mergers & Acquisitions
Growth Themes and Business Models

Tablet and Capsule Industry-Company Benchmarking based on Differentiated Technologies and Services

Company Benchmarking-Oral Drug Delivery Solutions and Services
Company Benchmarking Analysis
Companies to Watch

Growth Opportunity Universe

Growth Opportunity 1: Fixed Dose Combination Products for Chronic Diseases
Growth Opportunity 2: Medical Cannabidiol
Growth Opportunity 3: Phase-appropriate Services for Orphan Drugs
Growth Opportunity 4: Additive Manufacturing for Personalized Medicine

Best Practices Recognition

Best Practices Recognition

Frost Radar

Frost Radar

Next Steps

Benefits and Impacts of Growth Opportunities
Next Steps
Take the Next Step
List of Exhibits
Legal Disclaimer